Team Cure Cholangio

Name: Team Cure Cholangio
Address: Wilmington, DE, US
Telephone: 302-543-5225

A study in JAMA predicts that liver cancer and intrahepatic cholangiocarcinoma will be the third leading cause of cancer death by 2040.

THIS. IS. A. CRISIS.

Our Mission

Our Goal, Vision & Commitment

Our Events

Get Involved

Volunteer, Participate, or Donate

Mission & Team

Our Story

We are a 501c3 focused on raising awareness and money to fund research in hopes of a cure for Cholangiocarcinoma aka Bile Duct Cancer.

Cholangio What?

Cholangiocarcinoma (aka Bile Duct Cancer) is a deadly, aggressive, rare cancer that is difficult to diagnose, often diagnosed at a later stage, has limited treatment options, and has a very poor prognosis in many cases. Once a cancer of mostly men over 65, Cholangiocarcinoma (pronounced Ko-Lan-G-O-Car-Sin-O-Ma), also known as CCA, is now seen in men and women, some as young as 9 years of age. A study in JAMA predicts that liver cancer and intrahepatic cholangiocarcinoma will be the third leading cause of cancer death by 2040. With drugs often taking 10+ years to get to market, even with accelerated approval, THIS. IS. A. CRISIS.

We formed Team Cure Cholangio to raise much needed research monies. All proceeds from Team Cure Cholangio will be earmarked for research only.

Meet the Team

Jan Meyer

Chairman of the Board

Cholangiocarcinoma Warrior dx 2018

Mom stolen by cholangiocarcinoma in 2011

Appointed by Governor to the DE RDAC (Rare Disease Advisory Council) December 2023

Member of NORD’s Policy & Advocacy Task

2022 Governor's Outstanding Volunteer Service Award Recipient

2021 Mark R Clements Award for Excellence in Community Impact (Cholangiocarcinoma Foundation)

Jaye Pedante

Vice Chair

Cholangiocarcinoma Warrrior dx 2022

Lisa Johnson

CEO, Executive Director

Cholangiocarcinoma Warrior Dx 2023

Morgan
Worthington

Secretary

Cholangiocarcinoma

Warrior Dx 2023

Jan's Caregiver

Dean Meyer

Treasurer

Emeritus Board Members

Cameron Bolton
2022-2024

Kate Bolton
2022-2024

STUDY IN JAMA: "Lung cancer (63 000 deaths) was estimated to continue as the leading cause of cancer-related death in 2040, with pancreatic cancer (46 000 deaths) and liver and intrahepatic bile duct cancer (41 000 deaths) surpassing colorectal cancer (34 000 deaths) to become the second and third most common causes of cancer-related death, respectively. Breast cancer (30 000 deaths) was estimated to decrease to the fifth most common cause of cancer death"

Estimated Projection of US Cancer Incidence and Death to 2040 | Oncology | JAMA Network Open | JAMA Network